JP2018064580A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018064580A5 JP2018064580A5 JP2017239124A JP2017239124A JP2018064580A5 JP 2018064580 A5 JP2018064580 A5 JP 2018064580A5 JP 2017239124 A JP2017239124 A JP 2017239124A JP 2017239124 A JP2017239124 A JP 2017239124A JP 2018064580 A5 JP2018064580 A5 JP 2018064580A5
- Authority
- JP
- Japan
- Prior art keywords
- subtype
- seq
- amino acid
- acid sequence
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000712461 unidentified influenza virus Species 0.000 claims 55
- 125000003275 alpha amino acid group Chemical group 0.000 claims 54
- 101710154606 Hemagglutinin Proteins 0.000 claims 48
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 48
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 48
- 101710176177 Protein A56 Proteins 0.000 claims 48
- 239000000185 hemagglutinin Substances 0.000 claims 47
- 229920001184 polypeptide Polymers 0.000 claims 44
- 102000004196 processed proteins & peptides Human genes 0.000 claims 44
- 108090000765 processed proteins & peptides Proteins 0.000 claims 43
- 239000000203 mixture Substances 0.000 claims 26
- 239000012634 fragment Substances 0.000 claims 13
- 238000000034 method Methods 0.000 claims 11
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 230000002238 attenuated effect Effects 0.000 claims 10
- 230000002163 immunogen Effects 0.000 claims 10
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 6
- 241000712431 Influenza A virus Species 0.000 claims 5
- 238000001415 gene therapy Methods 0.000 claims 4
- 210000004408 hybridoma Anatomy 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 3
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 241000282693 Cercopithecidae Species 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 241000282577 Pan troglodytes Species 0.000 claims 1
- 241000845082 Panama Species 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18126309P | 2009-05-26 | 2009-05-26 | |
| US61/181,263 | 2009-05-26 | ||
| US22430209P | 2009-07-09 | 2009-07-09 | |
| US61/224,302 | 2009-07-09 | ||
| US30589810P | 2010-02-18 | 2010-02-18 | |
| US61/305,898 | 2010-02-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016014445A Division JP2016127846A (ja) | 2009-05-26 | 2016-01-28 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018064580A JP2018064580A (ja) | 2018-04-26 |
| JP2018064580A5 true JP2018064580A5 (enExample) | 2018-08-30 |
Family
ID=42352512
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513195A Expired - Fee Related JP5941841B2 (ja) | 2009-05-26 | 2010-05-26 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
| JP2016014445A Pending JP2016127846A (ja) | 2009-05-26 | 2016-01-28 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
| JP2017239124A Pending JP2018064580A (ja) | 2009-05-26 | 2017-12-14 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513195A Expired - Fee Related JP5941841B2 (ja) | 2009-05-26 | 2010-05-26 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
| JP2016014445A Pending JP2016127846A (ja) | 2009-05-26 | 2016-01-28 | 周期的投与によって作製されたインフルエンザウイルスに対するモノクローナル抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8673314B2 (enExample) |
| EP (1) | EP2435475B1 (enExample) |
| JP (3) | JP5941841B2 (enExample) |
| AU (1) | AU2010254136B2 (enExample) |
| CA (1) | CA2800182A1 (enExample) |
| WO (1) | WO2010138564A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011063127A1 (en) | 2009-11-18 | 2011-05-26 | University Of Medicine And Dentistry Of New Jersey | Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| EP2413962A1 (en) * | 2009-03-30 | 2012-02-08 | Mount Sinai School of Medicine | Influenza virus vaccines and uses thereof |
| AU2010254136B2 (en) | 2009-05-26 | 2016-09-29 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| US9849192B2 (en) | 2009-11-18 | 2017-12-26 | Rutgers, The State University Of New Jersey | Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| AU2011217903B2 (en) * | 2010-02-18 | 2017-03-02 | Mount Sinai School Of Medicine | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| MX2012011300A (es) | 2010-03-30 | 2012-11-29 | Sinai School Medicine | Vacunas del virus de influenza y usos de las mismas. |
| ES2728433T3 (es) * | 2011-04-21 | 2019-10-24 | Ology Bioservices Inc | Procedimientos para aislar y cuantificar un antígeno de vacunas |
| AR087364A1 (es) * | 2011-07-29 | 2014-03-19 | Pf Medicament | Anticuerpo anti-cxcr4 y su uso para la deteccion y dianostico de canceres |
| JP6253580B2 (ja) * | 2011-08-10 | 2017-12-27 | ランケナー インスティテュート フォー メディカル リサーチ | 自己免疫および炎症性疾患の治療のための方法および組成物 |
| GB201115214D0 (en) * | 2011-09-02 | 2011-10-19 | Health Prot Agency | Influenza virus antibody compositions |
| IN2014CN02114A (enExample) | 2011-09-20 | 2015-05-29 | Sinai School Medicine | |
| SG11201402780UA (en) | 2011-12-02 | 2014-10-30 | Aimm Therapeutics Bv | Influenza a virus specific antibodies |
| EA028433B1 (ru) * | 2012-03-08 | 2017-11-30 | Янссен Вэксинс Энд Превеншн Б.В. | Антитело, связывающееся с вирусами гриппа b и его применение |
| CN102621320B (zh) * | 2012-03-20 | 2014-07-02 | 中国检验检疫科学研究院 | 一种用于快速检测人禽流感病毒的非诊断性双抗体夹心法 |
| US9549993B2 (en) | 2012-10-02 | 2017-01-24 | Rutgers, The State University Of New Jersey | Specific delivery of toxins conjugated with antibodies to activate matripase |
| EP4154907A1 (en) | 2012-12-18 | 2023-03-29 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
| EP3003373A4 (en) | 2013-03-14 | 2016-10-19 | Contrafect Corp | COMPOSITION AND METHODS BASED ON INTRANASALLY RELEASED NEUTRALIZING ANTIBODIES FOR IMPROVED THERAPEUTIC EFFECTIVENESS |
| WO2014159960A1 (en) | 2013-03-14 | 2014-10-02 | Icahn School Of Medicine At Mount Sinai | Antibodies against influenza virus hemagglutinin and uses thereof |
| WO2014143886A2 (en) * | 2013-03-15 | 2014-09-18 | Edimer Pharmaceuticals, Inc. | Anti-ectodysplasin antibodies |
| US20160200799A1 (en) * | 2013-08-23 | 2016-07-14 | Fujita Health University | Anti-influenza virus neutralizing antibody |
| SG10202103140XA (en) * | 2013-10-02 | 2021-05-28 | Medimmune Llc | Neutralizing anti-influenza a antibodies and uses thereof |
| RU2720282C1 (ru) | 2014-02-04 | 2020-04-28 | Контрафект Корпорейшн | Антитела, подходящие для пассивной иммунизации против гриппа, и их композиции, комбинации и способы применения |
| US10639370B2 (en) | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| JP2018504412A (ja) | 2015-01-23 | 2018-02-15 | アイカーン スクール オブ メディシン アット マウント サイナイ | インフルエンザウイルスワクチン接種レジメン |
| JP2018518151A (ja) * | 2015-03-27 | 2018-07-12 | ユニバーシティ オブ サザン カリフォルニア | Ｂ７−ｈ４発現充実性腫瘍を処置するためのｃａｒ ｔ細胞 |
| EP3273994B1 (en) | 2015-03-27 | 2021-12-01 | University of Southern California | Car t-cell therapy directed to lhr for the treatment of solid tumors |
| EP3429586A4 (en) | 2016-03-18 | 2020-03-11 | Rutgers, the State University of New Jersey | TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO ANTI-MATRIPTASE ANTIBODIES BY IN VIVO-CLAVABLE LINKAGES |
| EP3455251A4 (en) | 2016-05-09 | 2020-04-22 | Icahn School of Medicine at Mount Sinai | WIDE NEUTRALIZING HUMAN ANTI-CYTOMEGALOVIRUS ANTIBODIES AND METHODS OF USE |
| WO2017218624A1 (en) | 2016-06-15 | 2017-12-21 | Icahn School Of Medicine At Mount Sinai | Influenza virus hemagglutinin proteins and uses thereof |
| US11254733B2 (en) | 2017-04-07 | 2022-02-22 | Icahn School Of Medicine At Mount Sinai | Anti-influenza B virus neuraminidase antibodies and uses thereof |
| US10766968B2 (en) | 2017-08-23 | 2020-09-08 | Brown University | Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer |
| WO2019040685A1 (en) * | 2017-08-23 | 2019-02-28 | Brown University | METHODS AND COMPOSITIONS RELATING TO ANTI-CHI3L1 ANTIBODY REAGENTS |
| EP3810634A4 (en) | 2018-06-21 | 2022-07-27 | Icahn School of Medicine at Mount Sinai | Mosaic influenza virus hemagglutinin polypeptides and uses thereof |
| AU2023283550A1 (en) * | 2022-06-09 | 2024-11-21 | Santa Ana Bio, Inc. | Antibodies targeting c-kit and/or siglec and uses thereof |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA836080B (en) | 1982-08-23 | 1984-04-25 | Scripps Clinic Res | Broad spectrum influenza antisera |
| US5182192A (en) * | 1987-03-27 | 1993-01-26 | The Wistar Institute | Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor |
| US5413923A (en) | 1989-07-25 | 1995-05-09 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
| US6001634A (en) | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
| US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
| US6887699B1 (en) | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| FR2664905B1 (fr) | 1990-07-18 | 1994-08-12 | Agronomique Inst Nat Rech | Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus. |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| JP3037554B2 (ja) * | 1993-04-20 | 2000-04-24 | 寳酒造株式会社 | 免疫原性人工ポリペプチド |
| US5589174A (en) | 1992-09-17 | 1996-12-31 | Takara Shuzo Co., Ltd. | Anti-human influenza virus antibody |
| US6337070B1 (en) * | 1993-04-29 | 2002-01-08 | Takara Shuzo Co., Ltd. | Polypeptides for use in generating anti-human influenza virus antibodies |
| GB9221654D0 (en) * | 1992-10-15 | 1992-11-25 | Scotgen Ltd | Recombinant human anti-cytomegalovirus antibodies |
| WO1994016109A1 (en) | 1993-01-15 | 1994-07-21 | Whitehead Institute For Biomedical Research | Membrane fusion events and means for altering same |
| WO1994017826A1 (en) | 1993-02-01 | 1994-08-18 | Smithkline Beecham Corporation | Vaccinal polypeptides |
| US5622701A (en) | 1994-06-14 | 1997-04-22 | Protein Design Labs, Inc. | Cross-reacting monoclonal antibodies specific for E- and P-selectin |
| JP4312259B2 (ja) | 1995-04-27 | 2009-08-12 | アムジェン フレモント インク． | 免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体 |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| DE69738539T2 (de) | 1996-12-03 | 2009-03-26 | Amgen Fremont Inc. | Vollkommen humane Antikörper die EGFR binden |
| NZ517903A (en) | 1999-09-24 | 2003-10-31 | Smithkline Beecham Biolog S | One dose intranasal influenza virus vaccine with split influenza viral antigens |
| US7521220B2 (en) | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| US6632620B1 (en) * | 2000-06-22 | 2003-10-14 | Andrew N. Makarovskiy | Compositions for identification and isolation of stem cells |
| US20040091503A1 (en) | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| CA2514177A1 (en) * | 2003-01-29 | 2004-08-12 | Josef Michl | Tolerance-induced targeted antibody production |
| ATE426412T1 (de) | 2003-01-30 | 2009-04-15 | Novartis Vaccines & Diagnostic | Adjuvante influenza-vakzine |
| US8592197B2 (en) * | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| EP2530147B1 (en) | 2004-05-25 | 2014-09-10 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
| CN101163714A (zh) | 2005-02-24 | 2008-04-16 | 马萨诸塞大学 | 流感病毒核酸、多肽及其用途 |
| AU2006252406B2 (en) | 2005-06-01 | 2012-05-17 | California Institute Of Technology | Method of targeted gene delivery using viral vectors |
| JP4758148B2 (ja) * | 2005-06-14 | 2011-08-24 | 泰三 宇田 | インフルエンザウイルスのヘマグルチニンに対する抗体酵素 |
| WO2007052058A1 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics Srl | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| PT2529747T (pt) | 2005-12-02 | 2018-05-09 | Icahn School Med Mount Sinai | Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações |
| WO2007066334A1 (en) | 2005-12-06 | 2007-06-14 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Improved influenza vaccine |
| US10183986B2 (en) | 2005-12-15 | 2019-01-22 | Industrial Technology Research Institute | Trimeric collagen scaffold antibodies |
| US8148085B2 (en) | 2006-05-15 | 2012-04-03 | Sea Lane Biotechnologies, Llc | Donor specific antibody libraries |
| WO2007134327A2 (en) * | 2006-05-15 | 2007-11-22 | Sea Lane Biotechnologies, Llc. | Neutralizing antibodies to influenza viruses |
| CA2657849A1 (en) | 2006-05-18 | 2008-05-08 | Pharmexa Inc. | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| SG173337A1 (en) | 2006-07-21 | 2011-08-29 | California Inst Of Techn | Targeted gene delivery for dendritic cell vaccination |
| MY170607A (en) | 2006-09-07 | 2019-08-20 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| EP4585610A3 (en) | 2006-09-11 | 2025-09-24 | Seqirus UK Limited | Making influenza virus vaccines without using eggs |
| EP2174957B1 (en) | 2007-06-15 | 2016-03-16 | Xiamen University | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| EP2014279A1 (en) | 2007-06-22 | 2009-01-14 | Pevion Biotech AG | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| JP5187883B2 (ja) * | 2007-07-18 | 2013-04-24 | 独立行政法人科学技術振興機構 | 抗原ペプチドおよびその利用 |
| WO2009025770A2 (en) * | 2007-08-17 | 2009-02-26 | Wyeth | A heterologous prime-boost immunization regimen |
| FR2921387B1 (fr) | 2007-09-26 | 2012-04-20 | Sanofi Pasteur | Procede de production du virus de la grippe |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| RU2010127156A (ru) | 2007-12-06 | 2012-01-20 | Дана-Фарбер Кэнсер Инститьют, Инк. (Us) | Антитела против вируса гриппа и их применение |
| EP2698380A1 (en) | 2008-03-28 | 2014-02-19 | Sea Lane Biotechnologies, LLC | Neutralizing molecules to viral antigens |
| GB0905570D0 (en) | 2009-03-31 | 2009-05-13 | Novartis Ag | Combined vaccines |
| EP2413962A1 (en) | 2009-03-30 | 2012-02-08 | Mount Sinai School of Medicine | Influenza virus vaccines and uses thereof |
| WO2010130636A1 (en) | 2009-05-11 | 2010-11-18 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof |
| AU2010254136B2 (en) | 2009-05-26 | 2016-09-29 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| CA2762042C (en) | 2009-06-24 | 2012-11-20 | Medicago Inc. | Chimeric influenza virus-like particles comprising hemagglutinin |
| JP5845180B2 (ja) | 2009-07-30 | 2016-01-20 | モウント シナイ スクール オフ メディシネ | インフルエンザウイルス及びそれらの使用 |
| AU2011217903B2 (en) | 2010-02-18 | 2017-03-02 | Mount Sinai School Of Medicine | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| MX2012011300A (es) | 2010-03-30 | 2012-11-29 | Sinai School Medicine | Vacunas del virus de influenza y usos de las mismas. |
| EP2596017B1 (en) | 2010-07-22 | 2019-04-03 | John W. Schrader | Cross-protective antibody against influenza viral infection |
| IN2014CN02114A (enExample) | 2011-09-20 | 2015-05-29 | Sinai School Medicine | |
| EP4154907A1 (en) | 2012-12-18 | 2023-03-29 | Icahn School of Medicine at Mount Sinai | Influenza virus vaccines and uses thereof |
-
2010
- 2010-05-26 AU AU2010254136A patent/AU2010254136B2/en not_active Ceased
- 2010-05-26 JP JP2012513195A patent/JP5941841B2/ja not_active Expired - Fee Related
- 2010-05-26 EP EP10720978.5A patent/EP2435475B1/en active Active
- 2010-05-26 US US12/788,103 patent/US8673314B2/en active Active
- 2010-05-26 CA CA2800182A patent/CA2800182A1/en not_active Abandoned
- 2010-05-26 WO PCT/US2010/036170 patent/WO2010138564A1/en not_active Ceased
-
2014
- 2014-01-23 US US14/162,354 patent/US9175069B2/en active Active
-
2015
- 2015-04-29 US US14/699,273 patent/US20150239960A1/en not_active Abandoned
-
2016
- 2016-01-28 JP JP2016014445A patent/JP2016127846A/ja active Pending
-
2017
- 2017-12-14 JP JP2017239124A patent/JP2018064580A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018064580A5 (enExample) | ||
| JP2012527899A5 (enExample) | ||
| JP2016063812A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| PE20181270A1 (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
| JP2016503413A5 (enExample) | ||
| HRP20200767T1 (hr) | Humanizirana anti-humana cd19 protutijela i postupci uporabe | |
| JP2013538553A5 (enExample) | ||
| JP2020500538A5 (enExample) | ||
| JP2011528901A5 (enExample) | ||
| JP2013531993A5 (enExample) | ||
| JP2018108086A5 (enExample) | ||
| JP2014237714A5 (enExample) | ||
| ES2685424T3 (es) | Anticuerpos anti-Jagged1 y procedimientos de uso | |
| JP2012034692A5 (enExample) | ||
| JP2015501149A5 (enExample) | ||
| JP2013502204A5 (enExample) | ||
| PE20141562A1 (es) | Anticuerpos anti-htra1 y metodos de uso | |
| NZ626520A (en) | Anti-lrp5 antibodies and methods of use | |
| JP2018518940A5 (enExample) | ||
| JP2013520996A5 (enExample) | ||
| JP2017534644A5 (enExample) | ||
| JP2018520334A5 (enExample) | ||
| JP2018505882A5 (enExample) | ||
| RU2013102073A (ru) | Антитела, подходящие для пассивной иммунизации против гриппа |